![\"EDIM](\"https:\/\/www.erweiterte-medizin.de\/wp-content\/uploads\/2018\/08\/EDIM-Titelbild-300x300.jpg\")
With cancers, the chances of recovery depend critically on an early diagnosis.\nSome established tests of the status of a tumour detect the disease too late or are not reliable enough; patients are worried.<\/p>\n
With cancers, the chances of recovery depend critically on an early diagnosis.
\nSome established tests of the status of a tumour detect the disease too late or are not reliable enough; patients are worried.<\/p>\n
EDIM blood testing (E<\/strong>pitope \u2013 D<\/strong>etection \u2013 i<\/strong>n \u2013 M<\/strong>onocytes – blood test) is used for early detection of tumours, the EDIM test procedure also provides an indication of the probability of response during chemotherapy and\/or radiation therapy for therapy monitoring, and the EDIM test also delivers a reliable blood analysis for purposes of follow-up care. The EDIM \u2013 TKTL1 determination is established with an immunohistochemical analysis, the EDIM technology on the macrophages circulating in the blood. EDIM blood analysis EDIM test – Milestone in cancer diagnosis With cancers, the chances of recovery depend critically on an early diagnosis. Some established tests of the status of a tumour detect the disease too late or are not reliable enough; patients are worried. EDIM blood testing (Epitope \u2013 Detection \u2013 in \u2013 Monocytes –…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":14836,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"content-type":"","footnotes":""},"class_list":["post-14839","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.erweiterte-medizin.de\/en\/wp-json\/wp\/v2\/pages\/14839"}],"collection":[{"href":"https:\/\/www.erweiterte-medizin.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.erweiterte-medizin.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.erweiterte-medizin.de\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erweiterte-medizin.de\/en\/wp-json\/wp\/v2\/comments?post=14839"}],"version-history":[{"count":0,"href":"https:\/\/www.erweiterte-medizin.de\/en\/wp-json\/wp\/v2\/pages\/14839\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.erweiterte-medizin.de\/en\/wp-json\/wp\/v2\/pages\/14836"}],"wp:attachment":[{"href":"https:\/\/www.erweiterte-medizin.de\/en\/wp-json\/wp\/v2\/media?parent=14839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nAccording to the latest scientific findings, with 90% precision the EDIM blood test offers high levels of sensitivity and specificity, and allows a conclusion to be drawn about tumour status a full 21 months earlier than all other conventional diagnostic procedures.
\nThe EDIM blood test has many advantages:
\nIt delivers a reliable early diagnosis for various types of cancer as well as evidence of recurrences, while at the same time no more tissue samples have to be taken.
\nOnly one small blood sample is required for the test.<\/p>\n
\nTKTL1 is an enzyme which may be upregulated in the presence of cancer cells when the tumour switches to glucose-dependent metabolism.
\nBut not all cancer cells switch to glucose-dependent metabolism, so not all cancer cells also express TKTL1.
\nThe question of whether the metabolic processes requiring glucose are an indicator of more aggressive cancer growth has not yet been scientifically resolved.<\/p>\n","protected":false},"excerpt":{"rendered":"